Skip to main content
. 2020 Apr 30;38(32):5071–5075. doi: 10.1016/j.vaccine.2020.04.070

Fig. 3.

Fig. 3

Overall topology of SARS-CoV-2-SPL monomer (A), SARS-CoV-SPL monomer (B) and SARS-CoV-2-SPL homotrimer (C).